EUVIMEDScopri EUVIMED
Crossref

POST-INFECTIOUS OPSOCLONUS-MYOCLONUS ATAXIA SYNDROME IN RICKETTSIAL DISEASE

JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY · 2025 · 32 (11)

DOI: 10.69980/7 ↗

At a glance

Journal article in JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2025.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Opsoclonus-Myoclonus Ataxia (OMA) syndrome is a rare neurological disorder that occurs in approximately 1 in 5,000,000 individuals per year in the general population. We report three cases of OMA syndrome presenting post-rickettsial infection.

Discussion

The prevalence of rickettsial infections in the South Indian population is estimated to be around 10% to 30% among acute undifferentiated febrile illnesses. While headache and encephalitis are well-known neurological manifestations of this infection, "dancing feet–dancing eyes" (OMA) is rarely seen. Methods & Results: We present three such unique cases. Rickettsial disease was confirmed using the Weil-Felix test. All patients were thoroughly screened for underlying paraneoplastic conditions. Every patient responded exceptionally well to a combination of pulse intravenous methylprednisolone (IVMP) and doxycycline.

Cite

APA

(2025). POST-INFECTIOUS OPSOCLONUS-MYOCLONUS ATAXIA SYNDROME IN RICKETTSIAL DISEASE. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 32(11). https://doi.org/10.69980/7

Vancouver

POST-INFECTIOUS OPSOCLONUS-MYOCLONUS ATAXIA SYNDROME IN RICKETTSIAL DISEASE. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY. 2025;32(11). doi:10.69980/7

BibTeX
@article{euvimed2025,
  title = {POST-INFECTIOUS OPSOCLONUS-MYOCLONUS ATAXIA SYNDROME IN RICKETTSIAL DISEASE},
  journal = {JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY},
  year = {2025},
  volume = {32},
  number = {11},
  doi = {10.69980/7}
}
Start for free →